6-Bromo-5-methyl[1,2,4]triazolo[1,5-a]pyridine

Catalog No. :
ACTZIB581
CAS No. :
746668-59-7
Molecular Formula :
C7H6BrN3
Molecular Weight :
212.05

IUPAC Name:6-bromo-5-methyl-[1,2,4]triazolo[1,5-a]pyridine

6-Bromo-5-methyl[1,2,4]triazolo[1,5-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$58.00Login to see priceIn stockIn stock
5g98%$200.00Login to see priceIn stockIn stock
25g98%$998.00Login to see priceInquiryIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-5-methyl[1,2,4]triazolo[1,5-a]pyridine
IUPAC Name6-bromo-5-methyl-[1,2,4]triazolo[1,5-a]pyridine
MDL No.MFCD09038165
Molecular FormulaC7H6BrN3
Molecular Weight212.05
SMILESBrC2=C([N]1C(=NC=N1)C=C2)C
InChI KeyLYFZTLWVHLYBEK-UHFFFAOYSA-N
Synonym6-Bromo-5-methyl[1,2,4]triazolo[1,5-a]pyridine | 746668-59-7 | 6-bromo-5-methyl-[1,2,4]triazolo[1,5-a]pyridine | MFCD09038165 | SCHEMBL5930819 | DTXSID50469709 | AKOS015842239 | FS-2906 | SY066267 | AM20061852 | FT-0685668 | EN300-1592162 | A865833 | J-518409 | 6-Bromo-5-methyl[1,2,
CAS No.746668-59-7
PubChem CID11629857

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTZIB581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACTZIB581 route product structure diagram
    ACTZIB581746668-59-7 In Stock
Inquiry

2. ACTZIB581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTZIB581 route product structure diagram
    ACTZIB581746668-59-7 In Stock
Inquiry

Comments (0)